Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 14 of 14 for “"angiotensin-converting-enzyme inhibitor"”.

  1. Combination Treatment of Angiotensin-II Receptor Blocker and Angiotensin-Converting-Enzyme Inhibitor in Non-Diabetic Renal Disease on Effect of Reducing Proteinuria

    BACKGROUND: The fact that angiotensin-converting enzyme inhibitors(ACEI) and angiotensin receptor blockers(ARB) antagonize the renin-angiotensin system at different levels suggests that these agents, already confirmed by clinical benefit in retarding the progression of chronic renal disease, may …

    ajou Repository record for Combination Treatment of Angiotensin-II Receptor Blocker and Angiotensin-Converting-Enzyme Inhibitor in Non-Diabetic Renal Disease on Effect of Reducing Proteinuria (opens in a new tab)

  2. Evaluating adherence to recommended clinical guidelines for the prevention of cardiovascular disease in patients with Type 2 diabetes mellitus at primary care level

    … managed with first-line- medication - an Angiotensin Converting Enzyme Inhibitor (ACEI). There was appropriate supporting documentation for only 39% not on first line therapy. A fifth (22%) with drug intolerance received the recommended alternative. Most were appropriately prescribed a …

    cape-town Repository record for Evaluating adherence to recommended clinical guidelines for the prevention of cardiovascular disease in patients with Type 2 diabetes mellitus at primary care level (opens in a new tab)

  3. Impact Of Time-Varying And Time-Invariant Measures Of Adherence To Secondary Prevention Therapies Post-Acute Myocardial Infarction: An Application Of Marginal Structural Models (MSMS)

    … and cohorts B (β-blocker therapy) and C (angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) therapy) included 1,021 and 1,025 patients, respectively. When accounting only for baseline covariates in a discrete-event time model the hazard for a recurrent AMI …

    mississippi Repository record for Impact Of Time-Varying And Time-Invariant Measures Of Adherence To Secondary Prevention Therapies Post-Acute Myocardial Infarction: An Application Of Marginal Structural Models (MSMS) (opens in a new tab)

  4. The effects of right ventricular pacing in the heart failure population

    … data-linkage study demonstrated that <br/>angiotensin receptor blocker or angiotensin converting enzyme inhibitor use <br/>was associated with improved mortality and less hospitalisation for heart <br/>failure in patients paced for complete heart block, who were likely to be <br/>exposed to …

    dundee Repository record for The effects of right ventricular pacing in the heart failure population (opens in a new tab)

  5. Establishing models of and characterising the genomic context of neutrophil hypersegmentation

    … via an investigation of the impact of the angiotensin converting enzyme inhibitor (ACEi) captopril, glucose concentration, and hypoxia. Furthermore, the current work outlines the optimisation of a laser capture microdissection (LCM) technique for the isolation of neutrophils, based on their …

    cambridge Repository record for Establishing models of and characterising the genomic context of neutrophil hypersegmentation (opens in a new tab)

  6. Apoptosis in the equine small intestine following experimental ischemia-reperfusion injury

    … injury and determining if use of an angiotensin converting enzyme inhibitor (enalaprilat) would ameliorate the apoptotic response. It was designed to determine if mucosal epithelial cells undergo apoptosis during the ischemia phase and also examined if apoptosis is significantly …

    vt Repository record for Apoptosis in the equine small intestine following experimental ischemia-reperfusion injury (opens in a new tab)

  7. Dapagliflozin Regresses Left Ventricular Hypertrophy in People with Type 2 Diabetes

    … mortality. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have been shown to reduce cardiovascular events, particularly heart failure, in cardiovascular outcome trials. One potential mechanism that may explain this benefit is regression of left ventricular hypertrophy (LVH); an …

    dundee Repository record for Dapagliflozin Regresses Left Ventricular Hypertrophy in People with Type 2 Diabetes (opens in a new tab)

  8. Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations

    … adherence monitoring tool using enalapril, an angiotensin-converting enzyme inhibitor for hypertension and heart failure, in a small cohort of African heart failure patients, and characterizing pharmacokinetics of esomeprazole, a proton pump inhibitor for hyperacidity and being investigated for …

    cape-town Repository record for Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations (opens in a new tab)

  9. A systematic review of outcomes associated with withholding or continuing angiotensinconverting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) prior to noncardiac surgery

    … surgery increasing numbers are taking either an angiotensin-converting enzyme inhibitor (ACE-I) or an angiotensin receptor blocker(ARB). The current recommendations whether to continue or withhold ACE-I and ARB in the perioperative period are conflicting. Previous metaanalyses have linked …

    cape-town Repository record for A systematic review of outcomes associated with withholding or continuing angiotensinconverting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) prior to noncardiac surgery (opens in a new tab)

  10. Corneal fibrosis therapies and investigations in the canine corna in vitro

    … safety and anti-fibrotic effects of the drugs, angiotensin-converting enzyme inhibitor (ACE-I) lisinopril and rho-kinase inhibitor (ROCK-I) fasudil, alone and in combination, on the canine cornea using an established in vitro model. Methods: To test the safety and efficacy of lisinopril and …

    missouri Repository record for Corneal fibrosis therapies and investigations in the canine corna in vitro (opens in a new tab)

  11. Cardiovascular magnetic resonance characterisation of the phenotype of resistant uncontrolled hypertension

    … a long-acting calcium channel blocker, an angiotensin converting enzyme inhibitor or angiotension receptor blocker and a diuretic. The prevalence of RH in South Africa is currently unknown, however, clinical reports suggest that it is not rare. Patients with RH are significantly predisposed …

    cape-town Repository record for Cardiovascular magnetic resonance characterisation of the phenotype of resistant uncontrolled hypertension (opens in a new tab)

  12. Magnetic resonance imaging studies of cardiac changes in diabetic and hypertensive rats

    … streptozotocin-treated rats. The effects of the angiotensin-converting enzyme inhibitor captopril upon such changes were also investigated. Finally, the MRI methods were also used to characterize the corresponding right ventricular changes in the spontaneously hypertensive rats (SHR), also for …

    cambridge Repository record for Magnetic resonance imaging studies of cardiac changes in diabetic and hypertensive rats (opens in a new tab)

  13. Central autonomic control in spontaneously hypertensive rats: a study on phasic phenomena during rapid-eye-movement sleep

    … by means of a chronic treatment with an angiotensin converting enzyme inhibitor, the Enalapril maleate, from the age of four weeks to the end of the experiment. All rats were implanted with electrodes for electroencephalographic and electromyographic recordings and with an arterial …

    bologna Repository record for Central autonomic control in spontaneously hypertensive rats: a study on phasic phenomena during rapid-eye-movement sleep (opens in a new tab)

  14. Pathophysiological role of aldosterone in cardiac remodelling after myocardial infarction

    … that the use of eplerenone in addition to an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker was well-tolerated. I also found an effect of eplerenone on two matrix metalloproteinases (MMPs) considered key enzymes in extracellular matrix turnover. Specifically, …

    glasgow Repository record for Pathophysiological role of aldosterone in cardiac remodelling after myocardial infarction (opens in a new tab)